Isogarcinol Extracted from Garcinia mangostana L ... - ACS Publications

This paper reports that it reduced imiquimod-induced psoriasis-like skin lesions in mice. It strongly attenuated the aberrant proliferation and differ...
0 downloads 0 Views 3MB Size
Subscriber access provided by HACETTEPE UNIVERSITESI KUTUPHANESI

Article

Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-induced Psoriasis-like Skin Lesions in Mice Shanzao Chen, Kesheng Han, Hu Li, Juren Cen, Yanfang Yang, Hezhen Wu, and Qun Wei J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.6b05207 • Publication Date (Web): 13 Jan 2017 Downloaded from http://pubs.acs.org on January 19, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 44

Journal of Agricultural and Food Chemistry

1

Isogarcinol Extracted from Garcinia mangostana L. Ameliorates

2

Imiquimod-induced Psoriasis-like Skin Lesions in Mice

3 4

Shanzao Chen†, Kesheng Han ‡, Hu Li†, Juren Cen†, Yanfang Yang§, Hezhen Wu§ &

5

Qun Wei†*

6 7

† Department of Biochemistry and Molecular Biology, Gene Engineering and

8

Biotechnology Beijing Key Laboratory, College of Life Sciences, Beijing Normal

9

University, Beijing, 100875, P. R. China

10

‡ Haikou Qili Pharmaceutical Co., Ltd, Haikou, 570216, P. R. China

11

§ College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430061, P. R.

12

China

13 14

* Corresponding author: Qun Wei

15

Address: Department of Biochemistry and Molecular biology, Gene Engineering and

16

Biotechnology Beijing Key Laboratory, School of Life Sciences, Beijing Normal

17

University, Beijing, 100875, P. R. China

18

Fax: 86-010-58807365.

19

Tel: 86-010-58807365

20

E-mail: [email protected]

21 22 1

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

23

ABSTRACT

24

Isogarcinol (YDIS), a natural compound extracted from Garcinia mangosana L., has a

25

significant immunosuppressive effect on systemic lupus erythematosus and

26

rheumatoid arthritis. Here we report that it reduced imiquimod-induced psoriasis-like

27

skin lesions in mice. It strongly attenuated the aberrant proliferation and

28

differentiation of keratinocytes. Moreover, the expression of genes involving the

29

interleukin-23(IL-23)/T-helper 17(Th17) axis was significantly inhibited in the dorsal

30

skin of the YDIS-treated mice, as was that of the other pro-inflammatory factors

31

TNF-α, IL-2 and even interferon(IFN)-γ. Furthermore, YDIS prevented the abnormal

32

distribution of T cell types and suppressed the differentiation of CD4+ T cells into

33

Th17 cells in the spleens of mice exposed to imiquimod. Interestingly, it elevated

34

numbers of regulatory T cells (Tregs) in the spleen and boosted IL-10 expression in

35

the skin. In agreement with the above, YDIS increased serum IL-10 and reduced

36

serum IL-17. It also caused less damage to the liver and kidneys of mice than

37

cyclosporine A (CsA), especially to kidneys. In vitro, YDIS caused more death of

38

HaCaT keratinocytes than CsA. It also strongly inhibited inflammatory factor

39

expression in lipopolysaccharide (LPS)-stimulated HaCaT cells. Our findings suggest

40

that YDIS is a promising immunosuppressive agent for treating psoriasis.

41 42

KEYWORDS: Isogarcinol, imiquimod-induced, psoriasis, T-helper 17 cell,

43

regulatory T cell, cyclosporine A, HaCaT

44 2

ACS Paragon Plus Environment

Page 2 of 44

Page 3 of 44

Journal of Agricultural and Food Chemistry

45

INTRODUCTION

46

Psoriasis is a common chronic, relapsing immune-mediated inflammatory dermatosis.

47

Histopathologically its lesions are mainly characterized by parakeratosis and

48

acanthosis in the epidermis, and blood vessel hyperplasia and inflammatory cell

49

infiltration in the dermis1. Psoriasis affects approximately 2~3% of the population

50

globally and most psoriatic sufferers are diagnosed as psoriasis vulgaris or plaque

51

psoriasis

52

physiological and psychological burdens. Moreover, it is not limited to skin

53

inflammation but linked to systemic metabolic comorbidities, such as type- Ⅱ

54

diabetes, cardiovascular diseases, atherosclerosis, arthritis and even melancholia,

55

because of immune system disorders associated with psoriasis4-6.

2, 3

. Though psoriasis does not cause death directly, it leads to massive

56

The underlying cause of psoriasis remains to be identified. Originally it was

57

thought that its onset was due to physical stress or infection, leading to activation of

58

innate immunity, mainly involving plasmacytoid dendritic cells (pDCs), which

59

produce large amounts of IFN-α that trigger adaptive immunity

60

cells were considered the key to psoriasis formation in the susceptible population.

61

However, deletion of IFN-α or IFN-γ (master cytokines of Th1 cells) only partially

62

relieved psoriatic symptoms

63

of innate immune cells, pro-inflammatory factors, T-helper 1 (Th1) and T-helper 17

64

(Th17) cells underlies the development of human psoriasis. Th17 cells, in particular,

65

may be the key to psoriasis

66

immune cells via cytokines or/and chemokines, and the innate immune cells such as

7, 8

. T-helper 1(Th1)

9, 10

. Current evidence suggests that a network composed

11, 12

. As psoriasis progresses, keratinocytes interact with

3

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

Page 4 of 44

67

dendritic cells (DCs) and macrophages in damaged psoriatic areas secrete various

68

cytokines that trigger naïve CD4+ T cells to differentiate into Th1 or Th17 cells,

69

which produce high levels of IFN-γ, IL-17 and IL-2213,

70

contribute to further skin inflammation and aberrant proliferation of keratinocytes.

71

Furthermore, abundant pro-inflammatory factors accelerate the recruitment of

72

inflammatory cells and the differentiation of lymphocytes15. Regulatory T cells (Tregs)

73

are important in maintaining immune homeostasis. Recent reports suggest that the

74

increased numbers of Th17 cells are accompanied by the accumulation of Tregs,

75

which increase the severity of psoriasis 16. In addition, under inflammatory conditions,

76

Tregs can switch into Th17 cells 17. Hence, a closed pro-inflammatory feedback loop

77

exacerbates the recurrent attack in psoriatic sufferers.

14

. These subsequently

78

In order to clarify the underlying pathological mechanisms of psoriasis, a

79

convenient and rapid model exhibiting most clinical features of psoriasis is needed.

80

Xenograft models, in which a skin graft from psoriatic tissue is transplanted to an

81

immunodeficient mouse, can produce the main psoriatic symptoms

82

establishing this model is difficult as the required experimental material is hard to

83

obtain. Another approach is to inject IL-23 into the subcutaneous tissue of the ear but

84

this only induces a few of the signs of psoriasis, mainly restricted to the skin of the ear.

85

Topical application of 5% imiquimod cream (IMQ) on the dorsal skin of mice can

86

dramatically activate antigen-presenting cells (APCs) and inflammatory cells in the

87

local area, which cause abnormal development of keratinocytes and activate adaptive

88

immunity 19. These characteristics resemble most of the features of clinical psoriasis 20, 4

ACS Paragon Plus Environment

18

, whereas

Page 5 of 44

Journal of Agricultural and Food Chemistry

89

21

, and this model has been widely used for the investigation of psoriasis.

90

Nowadays, psoriasis sufferers are treated with a variety of agents, including

91

corticosteroids and immunosuppressants, especially the latter. As the intensified

92

investigation, drugs affecting specific targets have been developed, such as the human

93

monoclonal antibodies etanercept (targeting TNF-α), ustekinumab (targeting

94

IL-12p40), ixekizumab and brodalumab (targeting IL-17 receptor A)

95

antibody-based immunomodulators can have strong therapeutic effects in early

96

treatment, whereas they cannot be used in a long term due to the immune deregulation

97

they cause26. The classical immunosuppressants, cyclosporine A (CsA) and tacrolimus

98

(FK506), are often used for moderate-to-severe psoriasis

99

relieve the psoriasis symptoms in the short term, they also lead to serious

21-25

. These

27, 28

. Although they can

29, 30

100

hepatotoxicity and nephrotoxicity

, and, what is worse, once patients discontinue

101

to take it, they may experience more serious symptoms 31. Hence, an effective agent

102

with low side-effects is urgently needed.

103

Isogarcinol (YDIS) is a natural bioactive compound extracted from the mangosteen

104

(including its ripe pericarp and bark) by Dr. Cen in our lab32. Mangosteen (Garcinia

105

mangostana L.) is a tropical fruit which as one of the agricultural cash crops is

106

popular with Asian. Mangosteen consists of milky-white tasty pulp and red-purple

107

pericarp. Mangosteen pericarp as a Tai folk medicine has been widely used against

108

diarrhea, dysentery and wound infection in Southeast Asia33,

109

interestingly, some reports recently indicate that mangosteen extract can serve as a

110

dietary antioxidiant and it can reduce high fat-diet induced hepatic steatosis35, 36. 5

ACS Paragon Plus Environment

34

. And more

Journal of Agricultural and Food Chemistry

111

Beside, crude extract of mangosteen enriches functional ice-cream with the effect on

112

lowering lipid and hepatoprotection

113

used as a dietary supplement in America owing to its healthcare function40.

37-39

. And recently, mangosteen extract has been

114

The structure of YDIS has been identified, whereas the researches or reports on its

115

function and effect are rare until we do some works. In our previous studies32, 41-43, we

116

were the first to report YDIS as a new potent immunosuppressant selected with

117

calcineurin (CN) as the target enzyme. Based on its significant effect on

118

anti-inflammation and immunomodulation32, we further investigated the effect of

119

YDIS as an immunosuppressive candidate on autoimmune diseases, such as

120

rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) and experimental

121

autoimmune encephalomyelitis (EAE)

122

disorder, and environmental and genetic factors may trigger or impact the psoriasis

123

event

124

disease 3. The definite pathogenesis of psoriasis remains unclear, and to study it from

125

the perspective of immunomodulation is a daring attempt. Based on these, we try to

126

investigate whether YDIS can regulate psoriasis.

41-43

. Psoriasis is a chronic inflammatory skin

2, 3, 11, 44

. Of course, some researchers also regard psoriasis as an autoimmune

127

In this study, we evaluate the effect of YDIS on IMQ-induced psoriasis-like skin

128

lesions and examine its effects on the expression of cytokines associated with

129

psoriasis and on a variety of relevant processes in vivo and in vitro.

130

MATERIALS AND METHODS

131

Mice and Reagents. 7-to-8-week-old female C57BL/6 mice were purchased from

132

Beijing Vital River Laboratory Animal Technology Co., Ltd. Mice were individually 6

ACS Paragon Plus Environment

Page 6 of 44

Page 7 of 44

Journal of Agricultural and Food Chemistry

133

housed and provided with purified water ad libitum. Before being used in experiments,

134

they were raised under conventional conditions for at least 1 week with ad libitum

135

access to food and water. All studies were approved by the Committee on Animal

136

Experimentation of Beijing Normal University and performed strictly in accordance

137

with institutional guidelines.

138

5% Imiquimod cream (Aldara) was purchased from iNova Pharmaceuticals

139

Australia Pty Ltd. Vaseline was produced by Kunlun Petrifaction (Baotou, China).

140

Cyclosporine A (CsA) was bought from TCI (Shanghai) Development Co., Ltd.

141

Isogarcinol (Purity>95%, measured by HPLC) was extracted and purified from the

142

mangosteen (including its pericarp and bark) in our laboratory by Dr. Cen32.

143

Development of IMQ-induced Psoriasis-Like Skin Lesions in a Murine

144

Model.Mice received a daily topical dose of 62.5 mg of commercially available

145

imiquimod cream on the shaved dorsal skin for 6 or 7 consecutive days as described

146

previously, and the equivalent amount of vaseline was applied to the control group.

147

One day before IMQ or vaseline treatment, mice were anesthetized by intraperitoneal

148

injection of 50mg/kg of sodium pentobarbital; their fur was shaved locally with an

149

electric clipper followed by a depilatory cream (Veet, Reckitt Benckiser, India).

150

To examine the efficacy of Isogarcinol (YDIS), mice were randomly divided into 4

151

groups (n=7 per group): a vehicle-treated vaselin-induced control group (abbreviated

152

to Control), a vehicle-treated IMQ-induced model group (Model), a YDIS

153

(100mg/kg)-treated IMQ-induced group (YDIS) and a CsA (50mg/kg)-treated

154

IMQ-induced group (CsA). The appropriate agents formulated in 200ul vehicle 7

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

155

(consisting of 12% ethanol, 23% normal saline, 5% Tween 80 and 60% peanut oil)

156

were administered by oral gavage with a stomach-filling needle prior to application of

157

62.5mg IMQ cream, while the control and model groups received only 200ul vehicle.

158

The time we first treated was considered as day 0.

159

Scoring the Severity of Psoriasis-like Skin Lesions. A modified clinical Psoriasis

160

Area and Severity Index (PASI) was used to score the severity of dorsal skin

161

inflammation, and the affected skin area was not taken into consideration in the

162

overall score. Erythema, scaling, and skin thickness were scored blind and

163

independently on a scale from 0 to 4: 0, none; 1, slight; 2, moderate; 3, marked; 4,

164

very marked. The cumulative score of the above 3 targets served as a measure of the

165

severity of dorsal inflammation (scale 0-12).

166

Quantitative Real-time Reverse Transcription PCR. Total RNA was isolated

167

from fresh dorsal biopsies of sacrificed mice using TRIzol reagent (Invitrogen, USA).

168

cDNA was synthesized using Reverse Transcriptase M-MLV (Rnase H-) and Oligo

169

(dT)-18 primer. The mRNAs of factors were detected using an ABI5700 Real-time

170

PCR system (Thermo Fisher, USA). Glyceraldehyde-3-phosphate dehydrogenase

171

(GAPDH) was taken as reference gene to normalize and analyze in parallel all the

172

gene transcription using the 2-∆∆CT method. Primer sequences designed to detect the

173

gene expression in mouse were as follows: IFN-γ, forward primer, 5’- GTT GCT GAT

174

GGC CTG ATT GTC-3’, reverse primer, 5’-CGG CAC AGT CAT TGA AAG CCT

175

A-3’; IL-4, forward primer, 5’-ACG GAG ATG GAT GTG CCA AAC-3’; reverse

176

primer, 5’- AGC ACC TTG GAA GCC CTA CAG A-3’; IL-17A, forward primer, 8

ACS Paragon Plus Environment

Page 8 of 44

Page 9 of 44

Journal of Agricultural and Food Chemistry

177

5’-TCA TGT GGT GGT CCA GCT TTC-3’, reverse primer, 5’-GAA GGC CCT CAG

178

ACT ACC TCA A-3’; IL-22, forward primer, 5’-TTT CCT GAC CAA ACT CAG

179

CA-3’, reverse primer, 5’- CTG GAT GTT CTG GTC GTC AC-3’; IL-23p19, forward

180

primer, 5’-ACA TGC ACC AGC GGG ACA TA-3’, Reverse primer, 5’-CTT TGA

181

AGA TGT CAG AGT CAA GCA G-3’ ; TNF-α, forward primer, 5’-TAT GGC CCA

182

GAC CCT CAC A-3’, reverse primer, 5’-GGA GTA GAC AAG GTA CAA CCC

183

ATC-3’ ; GAPDH, forward primer, 5’- TGT GTC CGT CGT GGA TCT GA-3’,

184

reverse primer, 5’-TTG CTG TTG AAG TCG CAG GAG-3’; RoRγt, forward primer,

185

5’-TCT GCA AGA CTC ATC GAC AAG G-3’,reverse primer, 5’-CAC ATG TTG

186

GCT GCA CAG G-3’; FoxP3, forward primer, 5’-TGC CTT CAG ACG AGA CTT

187

GGA-3’, reverse primer, 5’-GGC ATT GGG TTC TTG TCA GAG-3’. Primers used

188

for detecting the corresponding gene expression in HaCaT cell line: IL-6, forward

189

primer, 5’-AGA GTA GTG AG GAA CAA GCC-3’, reverse primer, 5’-TAC ATT

190

TGC CGA AGA GCC CT-3’; TNF-α, forward primer, 5’-TCC TTC AGA CAC CCT

191

CAA CC-3’, reverse primer, 5’-AGG CCC CAG TTT GAA TTC TT-3’; β-actin,

192

forward primer, 5’-AGG GAA ATC GTG CGT GAC AT-3’, reverse primer, 5’-TCC

193

TGC TTG CTG ATC CAC AT-3’; S100A7, forward primer, 5’-GCA TGA TCG ACA

194

TGT TTC ACA AAT ACA C-3’, reverse primer, 5’- TGG TAG TCT GTG GCT ATG

195

TCT CCC-3’; S100A9, forward primer, 5’-GCT CCT CGG CTT TGA CAG AGT

196

GCA AG-3’, reverse primer, 5’-GCA TTT GTG TCC AGG TCC TCC ATG ATG

197

TGT-3’.

198

Cell Preparation and Flow Cytometric Analysis. IMQ application and 9

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

199

corresponding agent oral administration lasted for 6 days. Namely, 24 hours after the

200

final treatment the mice were sacrificed. Spleens were harvested into a tissue culture

201

dish with 0.9% normal saline, and then minced and filtered through a 70µm nylon

202

mesh in RPMI 1640 medium without fetal bovine serum. Erythrocytes were lysed,

203

and the suspension was centrifuged and cells resuspended in PBS (without calcium

204

and magnesium). For staining cell surface antigens, lymphocytes were collected and

205

treated with Fc-block (BD Pharmingen, USA), and then stained with FITC rat

206

anti-mouse CD3 complex (145-2C11, BD Pharmingen), APC rat anti-mouse CD4

207

(GK1.5, BD Pharmingen), or PE rat anti-mouse CD8α (53-6.7, BD Pharmingen).

208

APC- or FITC-labeled rat anti-mouse IFN-γ (XMG1.2, BD Pharmingen), PE rat

209

anti-mouse IL-4 (11B11, BD Pharmingen), and PE rat anti-mouse IL-17

210

(TC11-18H10, BD Pharmingen) were used for intracellular staining of cytokines. In

211

these procedures, splenocytes were pre-incubated for at least 24 hours at 37︒C and in

212

5% CO2. In the last 6 hours, they were stimulated with phorbol 12-myristate

213

13-acetate (60ng/ml) and ionomycin (900ng/ml). In some cases, they were also

214

activated by plate-coated purified anti-CD3 monoclonal antibody (10µg/ml) for 48

215

hours. In all cases, Golgistop inhibitor was added for the final 6 hours. At the end of

216

incubation, the splenocytes were harvested and blocked with Fc-block before

217

extracellular staining. After cell surface staining, the splenocytes were fixed and

218

permeabilized with a BD Cytofix/CytopermTM Fixation/Permeabilization Kit, then

219

stained for the appropriate cytokines. To stain FoxP3, cells were directly stained

220

without stimulation using the FoxP3 staining Buffer Set (eBiosciences, USA). 10

ACS Paragon Plus Environment

Page 10 of 44

Page 11 of 44

Journal of Agricultural and Food Chemistry

221

CD4+ T Cell Isolation. Mice in control group and model group were treated for 6

222

days as indicated. Namely, spleens were harvested on day 6. Single-cell suspensions

223

were prepared, and CD4+ cells were separated from splenocytes via magnetic

224

microbeads by CD4+ T Cell Isolation Kit (Miltenyi Biotec, Germany) and MS

225

Columns (Miltenyi Biotec, Germany). All our procedures are in accordance with the

226

manufacturers’ instruction. The purity of CD4+ T cell fractions were always > 95%.

227

Histopathology and Immunohistochemistry Analyses. Dorsal skin grafts were

228

collected, and immersed in 4% paraformaldehyde solution to fix them for 3-5 days.

229

Briefly, the tissues were embedded in paraffin and sliced into 5µm. Then

230

deparaffinized sections were stained with haematoxylin and eosin (H&E). For

231

immunohistochemistry,

232

specimens were deparaffinized, antoclaved, heat-processed for antigen retrieval in

233

citrate saline buffer, and incubated with purified rabbit anti-mouse Ki-67 (abcam, UK)

234

at 1:50 dilution overnight at 4︒C. All procedures were performed according to the

235

manufacturers’ guidelines.

paraformaldehyde-fixed

and

paraffin-embedded

skin

236

Enzyme-linked Immunosorbent Assays (ELISA) for Cytokines. Cytokines in

237

serum or culture supernatant were assayed with the corresponding ELISA kits

238

(Neobioscience, China).

239

Statistical Analysis. Data from at least three experiments were analyzed using

240

Student’s t-test or one-way analysis of variance followed by Bonferroni’s Multiple

241

Comparison test with GraphPad Prism 5.0. Values are presented as mean±SEM, and

242

P